article thumbnail

Analytica 2024 in overview

European Pharmaceutical Review

International participation and trending topics With over 900 exhibitors, analytica 2024 promises an impressive lineup. The four analytica forums offer practical best-practice lectures, with the Occupational Safety and Security Forum highlighting dangers in daily laboratory work through impressive live demonstrations.

article thumbnail

Vaccine demonstrates benefit in delaying cancer relapse

European Pharmaceutical Review

It also showed a favourable safety profile, which is exciting.” A Phase II trial will commence later in 2024, utilising a new formulation of the ELI-002 cancer vaccine, targeting additional KRAS mutations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Intrinsic Medicine enters merger with Phoenix Biotech

Pharmaceutical Technology

Intrinsic Medicine has signed a definitive business combination agreement with special purpose acquisition (SPAC) firm Phoenix Biotech Acquisition to create a public company. The merged business will use human milk biology for the treatment of Gut-Brain Axis (GBA) disorders. in cash held in trust to Intrinsic. .

article thumbnail

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Medgadget

This layer of specialized endothelium significantly restricts which drug molecules can enter the brain, normally greatly limiting treatment options for patients with brain-based disease. CraniUS , a medtech company based in Baltimore, has developed the NeuroPASS drug delivery system.

Medicine 106
article thumbnail

4 Biotech Executives Share Strategies Behind Successful Fund Raises

PM360

Addimmune , which is exploring gene therapy technologies that treat and cure HIV, went the special purpose acquisition company (SPAC) route where a publicly traded company is created for the purpose of acquiring or merging with an existing company. The deal is expected to close in 2024. and 10X Capital Venture Acquisition Corp.

article thumbnail

Breaking Down Malaysia's Budget 2023

Contrarian Sales Techniques

The Luxury Goods Tax is being implemented this year, and a Capital Gains Tax on unlisted shares may be introduced in 2024. RM1 billion will be allocated to strengthen domestic safety, including acquiring more than 2,100 units of body cameras for the Royal Malaysia Police. Economic growth and tax policies: The government predicts a 4.5%

article thumbnail

Covid-19 Omicron boosters will reinvigorate injectables manufacturing

Pharmaceutical Technology

On 25 June, Pfizer and BioNTech (Mainz, Germany) reported pivotal Phase II/III data demonstrating the safety, tolerability and immunogenicity of two Omicron-adapted vaccine candidates. The expansion will be operational in 2024. Pfizer’s Omicron vaccine aiming for autumn boosters.